Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
O'Garra, A., Steinman, L. and Gijbels, K. (1997). CD4+ T-cell subsets in
autoimmunity. Curr. Opin. Immunol. 9: 872-883.
Old, LJ (1996). Immunotherapy for cancer. Sci. Am. 275(3): 136-143.
Olie, RA, Simoes-Wust, AP, Baumann, B., Leech, SH, Fabbro, D., Stahel, RA
and Zangemeister-Wittke, U. (2000). A novel antisense oligonucleotide
targeting survivin expression induces apoptosis and sensitizes lung cancer
cells to chemotherapy. Cancer Res. 60: 2805-2809.
Onizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T. and Nakayama, E.
(1999). Tumor rejection by in vivo administration of anti-CD25 (interleukin-2
receptor alpha) monoclonal antibody. Cancer Res. 59(13): 3128-3133.
Ossendorp, F., Mengede, E., Camps, M., Filius, R. and Melief, CJ (1998).
Specific T helper cell requirement for optimal induction of cytotoxic T
lymphocytes against major histocompatibility complex class II negative
tumors. J. Exp. Med. 187(5): 693-702.
Owen, CA and Campbell, EJ (1999). The cell biology of leukocyte-mediated
proteolysis. J. Leukoc. Biol. 65: 137-150.
Panelli, MC., Bettinotti, MP, Lally, K., Ohnmacht, GA, Li, Y., Robbins, P.,
Riker, A., Rosenberg, SA and Marincola, FM (2000a). A tumor-infiltrating
lymphocyte from a melanoma metastasis with decreased expression of
melanoma differentiation antigens recognizes MAGE-12. J. Immunol. 164(8):
4382-4392.
Panelli, MC, Wunderlich, J., Jeffries, J., Wang, E., Mixon, A., Rosenberg, SA
and Marincola, FM (2000 b). Phase 1 study in patients with metastatic
melanoma of immunization with dendritic cells presenting epitopes derived
114